| 产品编号 |
bs-41336P |
| 英文名称 |
Recombinant human NMP-22 protein, His
|
| 中文名称 |
重组人核基质蛋白22 |
| 别 名 |
NMP 22; NMP22; Nuclear matrix protein 22; Nuclear matrix protein22; Nuclear matrix protein-22; Recombinant human NMP-22 protein, His |
| 克 隆 号 |
|
| 理论分子量 |
47 kDa |
| 检测分子量 |
52 |
| 性 状 |
Lyophilized or Liquid |
| 浓 度 |
＞0.5 mg/ml |
| 物 种 |
Human |
| 序 列 |
2-410/2115 |
| 纯 度 |
>90% as determined by SDS-PAGE |
| 纯化方法 |
AC |
| 内毒素 |
Not analyzed |
| 表达系统 |
E.coli |
| 活性 |
Not tested |
| 标签 |
His |
| 缓 冲 液 |
20mM Tris-HCl (pH8.0). |
| 保存条件 |
Stored at -70℃ or -20℃. Avoid repeated freeze/thaw cycles. |
| 注意事项 |
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| 产品介绍 |
Healthy individuals generally have very small amounts of NMP22 protein in the urine. However, the level of NMP22 protein is often elevated in the urine of patients with bladder cancer, even at early stages of the disease.1 The Alere NMP22 Test is an enzyme immunoassay for the quantitative determination of nuclear mitotic apparatus protein (NuMA) in stabilized voided urine. NuMA is an abundant component of the nuclear matrix proteins (NMP22). The Alere NMP22?BladderChek?Test is the only in-office test approved by the FDA as an aid in the diagnosis and monitoring of bladder cancer in conjunction with standard diagnostic procedures. Both assays are painless and non-invasive and detect elevated levels of NMP22 protein.
|
| 产品图片 |
The purity of the protein is greater than 90% as determined by reducing SDS-PAGE.
|
|
|
